Anti-Toxoplasma gondii antibodies as a risk factor for the prevalence and severity of systemic lupus erythematosus

Table 1 Prevalence of anti-Toxoplasma gondii antibodies immunoglobulin G in serum samples of patients with different autoimmune diseases and healthy controls

Study population	ATxA IgG⁺	P value^a
Healthy controls	53/908 (5.8%)
Patients with an AID
Rheumatoid arthritis	12/151 (8.0%)	0.319
Sjögren’s syndrome	33/219 (15.1%)	< 0.0001*
Systemic lupus erythematosus	144/863 (16.7%)	< 0.0001*

AID Autoimmune disease, ATxA IgG⁺, anti-Toxoplasma gondii antibodies immunoglobulin G-positive, ATxA IgG⁻ anti-Toxoplasma gondii antibodies immunoglobulin G-negative
*Statistically significant
^aP value for the comparison with matched healthy controls

ISSN: 1756-3305